David James Jr. Papke, M.D., Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 11 | 2024 | 1151 | 4.460 |
Why?
|
Glomus Tumor | 3 | 2023 | 62 | 2.430 |
Why?
|
Sarcoma | 6 | 2024 | 1786 | 2.000 |
Why?
|
Myofibroblasts | 2 | 2024 | 207 | 1.500 |
Why?
|
DNA Mismatch Repair | 4 | 2022 | 429 | 1.460 |
Why?
|
Hemangioma | 3 | 2023 | 727 | 1.300 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 453 | 1.220 |
Why?
|
beta Catenin | 2 | 2022 | 1043 | 1.070 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2022 | 614 | 1.000 |
Why?
|
Bone Neoplasms | 3 | 2022 | 2532 | 0.970 |
Why?
|
Gene Fusion | 3 | 2023 | 351 | 0.960 |
Why?
|
Hemangioendothelioma | 2 | 2022 | 111 | 0.920 |
Why?
|
Calmodulin-Binding Proteins | 2 | 2022 | 232 | 0.880 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 218 | 0.880 |
Why?
|
Angiofibroma | 1 | 2023 | 55 | 0.870 |
Why?
|
RNA-Binding Protein EWS | 1 | 2024 | 210 | 0.860 |
Why?
|
Endometrial Hyperplasia | 2 | 2020 | 98 | 0.860 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2023 | 55 | 0.850 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2022 | 34 | 0.820 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4312 | 0.790 |
Why?
|
Dermatofibrosarcoma | 1 | 2022 | 48 | 0.780 |
Why?
|
Fibrosarcoma | 1 | 2023 | 308 | 0.780 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2022 | 63 | 0.770 |
Why?
|
Lipoma | 1 | 2023 | 292 | 0.770 |
Why?
|
Immunohistochemistry | 7 | 2024 | 11058 | 0.760 |
Why?
|
Hamartoma | 1 | 2023 | 232 | 0.750 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2021 | 70 | 0.750 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2023 | 380 | 0.740 |
Why?
|
Fasciitis | 1 | 2021 | 66 | 0.720 |
Why?
|
Chondroblastoma | 1 | 2020 | 48 | 0.710 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2020 | 67 | 0.700 |
Why?
|
Liposarcoma | 1 | 2023 | 283 | 0.700 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5796 | 0.690 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 367 | 0.680 |
Why?
|
Adenocarcinoma | 3 | 2022 | 6311 | 0.670 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 359 | 0.640 |
Why?
|
Mesenchymoma | 1 | 2019 | 49 | 0.640 |
Why?
|
Esophagogastric Junction | 1 | 2021 | 343 | 0.630 |
Why?
|
Precancerous Conditions | 2 | 2022 | 979 | 0.620 |
Why?
|
Colorectal Neoplasms | 4 | 2022 | 6853 | 0.620 |
Why?
|
Vascular Neoplasms | 1 | 2019 | 167 | 0.600 |
Why?
|
Ligand-Gated Ion Channels | 2 | 2014 | 8 | 0.580 |
Why?
|
Endometrial Neoplasms | 3 | 2023 | 1361 | 0.580 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2023 | 2499 | 0.560 |
Why?
|
Point Mutation | 1 | 2022 | 1594 | 0.540 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 649 | 0.540 |
Why?
|
Telomerase | 1 | 2021 | 747 | 0.520 |
Why?
|
Translocation, Genetic | 1 | 2021 | 1388 | 0.510 |
Why?
|
Receptors, Nicotinic | 3 | 2014 | 494 | 0.510 |
Why?
|
Ion Channel Gating | 3 | 2014 | 436 | 0.500 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 796 | 0.490 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 951 | 0.460 |
Why?
|
Stomach Neoplasms | 2 | 2021 | 1422 | 0.440 |
Why?
|
Pathology, Clinical | 1 | 2017 | 375 | 0.440 |
Why?
|
Influenza A virus | 1 | 2016 | 458 | 0.410 |
Why?
|
Optic Nerve Diseases | 1 | 2016 | 342 | 0.410 |
Why?
|
Microscopy | 1 | 2017 | 880 | 0.400 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2024 | 504 | 0.370 |
Why?
|
Medical Informatics | 1 | 2018 | 732 | 0.370 |
Why?
|
Receptors, Purinergic | 1 | 2011 | 66 | 0.370 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1655 | 0.360 |
Why?
|
Algorithms | 3 | 2020 | 13946 | 0.350 |
Why?
|
Carcinoma | 1 | 2021 | 2334 | 0.340 |
Why?
|
Receptors, AMPA | 1 | 2011 | 323 | 0.330 |
Why?
|
Visual Fields | 1 | 2016 | 1053 | 0.330 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3615 | 0.330 |
Why?
|
Influenza Vaccines | 1 | 2016 | 770 | 0.310 |
Why?
|
Repressor Proteins | 3 | 2024 | 2981 | 0.310 |
Why?
|
Gene Rearrangement | 2 | 2024 | 1122 | 0.300 |
Why?
|
Humans | 43 | 2024 | 759255 | 0.290 |
Why?
|
Biopsy | 1 | 2019 | 6772 | 0.280 |
Why?
|
Neurotransmitter Agents | 1 | 2011 | 661 | 0.280 |
Why?
|
Mutation | 4 | 2022 | 29877 | 0.280 |
Why?
|
Visual Acuity | 1 | 2016 | 2619 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9269 | 0.250 |
Why?
|
Influenza, Human | 1 | 2016 | 1533 | 0.240 |
Why?
|
Vaccination | 1 | 2016 | 3354 | 0.230 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2023 | 89 | 0.220 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2023 | 1889 | 0.220 |
Why?
|
Adult | 15 | 2024 | 219390 | 0.220 |
Why?
|
Receptors, Glycine | 2 | 2014 | 33 | 0.210 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2023 | 77 | 0.210 |
Why?
|
Young Adult | 8 | 2024 | 58483 | 0.210 |
Why?
|
Synaptophysin | 1 | 2022 | 139 | 0.200 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2022 | 36 | 0.200 |
Why?
|
Hepatitis | 1 | 2023 | 231 | 0.190 |
Why?
|
Microsatellite Instability | 2 | 2022 | 715 | 0.190 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
|
Succinate Dehydrogenase | 1 | 2022 | 145 | 0.190 |
Why?
|
Endometrium | 2 | 2020 | 404 | 0.190 |
Why?
|
Amiodarone | 1 | 2022 | 218 | 0.180 |
Why?
|
Alkaline Phosphatase | 1 | 2023 | 866 | 0.180 |
Why?
|
Patch-Clamp Techniques | 2 | 2014 | 932 | 0.180 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 243 | 0.170 |
Why?
|
Male | 16 | 2024 | 358719 | 0.170 |
Why?
|
Tissue Array Analysis | 1 | 2022 | 551 | 0.170 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 5789 | 0.170 |
Why?
|
Female | 19 | 2024 | 390240 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2014 | 1694 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2019 | 53 | 0.160 |
Why?
|
Middle Aged | 13 | 2024 | 219653 | 0.160 |
Why?
|
Aged | 10 | 2024 | 168617 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 4 | 2024 | 17750 | 0.150 |
Why?
|
Child | 5 | 2024 | 79623 | 0.140 |
Why?
|
Search Engine | 1 | 2018 | 138 | 0.140 |
Why?
|
Adolescent | 5 | 2024 | 87560 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1588 | 0.140 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 376 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.130 |
Why?
|
Fatty Liver | 1 | 2022 | 777 | 0.130 |
Why?
|
Membrane Potentials | 3 | 2014 | 1095 | 0.130 |
Why?
|
Stromal Cells | 1 | 2021 | 1327 | 0.130 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15264 | 0.120 |
Why?
|
Actins | 1 | 2022 | 2048 | 0.120 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1066 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.120 |
Why?
|
Giant Cell Arteritis | 1 | 2018 | 296 | 0.110 |
Why?
|
Potassium Chloride | 1 | 2014 | 233 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 996 | 0.110 |
Why?
|
Protein Structure, Secondary | 2 | 2014 | 1230 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1111 | 0.110 |
Why?
|
Phenotype | 2 | 2022 | 16532 | 0.110 |
Why?
|
Transcription Factors | 2 | 2023 | 12106 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4111 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1612 | 0.110 |
Why?
|
Calcinosis | 1 | 2021 | 1477 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1800 | 0.100 |
Why?
|
Epithelial Cells | 2 | 2021 | 3664 | 0.100 |
Why?
|
Acetylcholine | 1 | 2014 | 629 | 0.100 |
Why?
|
Glycine | 1 | 2014 | 663 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2939 | 0.090 |
Why?
|
Histones | 1 | 2020 | 2582 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3537 | 0.080 |
Why?
|
Trans-Activators | 1 | 2019 | 2860 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4491 | 0.080 |
Why?
|
Skin | 1 | 2022 | 4467 | 0.080 |
Why?
|
Forecasting | 1 | 2017 | 2931 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2014 | 4262 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12964 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1737 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3073 | 0.070 |
Why?
|
Electric Stimulation | 1 | 2011 | 1736 | 0.060 |
Why?
|
Prevalence | 1 | 2022 | 15641 | 0.060 |
Why?
|
Protein Conformation | 2 | 2012 | 3970 | 0.060 |
Why?
|
Computational Biology | 1 | 2017 | 3505 | 0.060 |
Why?
|
Synaptic Transmission | 1 | 2011 | 1169 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3204 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3846 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2867 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20031 | 0.060 |
Why?
|
Kinetics | 1 | 2011 | 6380 | 0.050 |
Why?
|
Software | 1 | 2017 | 4421 | 0.050 |
Why?
|
Models, Molecular | 2 | 2012 | 5427 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2017 | 2532 | 0.050 |
Why?
|
Models, Neurological | 1 | 2011 | 1757 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2023 | 58867 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 1428 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10827 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7460 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 317 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6542 | 0.050 |
Why?
|
Urea | 1 | 2023 | 443 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29561 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11324 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2012 | 3824 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35941 | 0.040 |
Why?
|
Lysine | 1 | 2023 | 1002 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 41935 | 0.040 |
Why?
|
Temporal Arteries | 1 | 2018 | 143 | 0.040 |
Why?
|
Liver | 2 | 2023 | 7514 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2041 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 850 | 0.030 |
Why?
|
Time Factors | 2 | 2014 | 40109 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2022 | 64879 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22019 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1085 | 0.030 |
Why?
|
Animals | 4 | 2014 | 167838 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2023 | 2630 | 0.030 |
Why?
|
Cysteamine | 1 | 2012 | 24 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3619 | 0.020 |
Why?
|
Torpedo | 1 | 2009 | 170 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2009 | 406 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2012 | 967 | 0.020 |
Why?
|
Thermodynamics | 1 | 2009 | 599 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1978 | 0.020 |
Why?
|
Mice | 2 | 2012 | 81138 | 0.020 |
Why?
|
Nicotinic Agonists | 1 | 2009 | 265 | 0.020 |
Why?
|
Oocytes | 1 | 2012 | 1169 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9194 | 0.020 |
Why?
|
Chlorides | 1 | 2009 | 664 | 0.020 |
Why?
|
Magnesium | 1 | 2009 | 810 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5066 | 0.020 |
Why?
|
Potassium | 1 | 2009 | 1318 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1252 | 0.010 |
Why?
|
Sodium | 1 | 2009 | 1601 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8929 | 0.010 |
Why?
|
Water | 1 | 2009 | 1401 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6053 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41247 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5721 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6195 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15636 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54204 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 80121 | 0.010 |
Why?
|